FDA Approves First Crispr Treatment That Might Cure Sickle Cell
The Food and Drug Administration approved a new gene editing therapy for sickle cell disease, its first green light for a Crispr treatment.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news topline Source Type: news
More News: Food and Drug Administration (FDA) | Genetics | Pharmaceuticals | Science | Sickle Cell Anemia